BioAgilytix Secures Significant New Investment from Global Investor Cinven to Fuel Continued Long-Term Growth

The Latest News from BioAgilytix

5 November, 2013

BioAgilytix adds 2 Gyros Workstations to Existing Suite of Immunoassay Platforms

BioAgilytix, a leading bioanalytical testing laboratory specializing in immunoassays and cell-based assays, announced today the introduction of two Gyrolab xP workstations to its existing suite of immunoassay platforms. Dr. Afshin Safavi,…

Read More